0000908662-16-000402.txt : 20160119
0000908662-16-000402.hdr.sgml : 20160118
20160119161946
ACCESSION NUMBER: 0000908662-16-000402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160114
FILED AS OF DATE: 20160119
DATE AS OF CHANGE: 20160119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY MARY ANN
CENTRAL INDEX KEY: 0001261974
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 161348532
MAIL ADDRESS:
STREET 1: 201 W 70TH ST, SUITE 23K
CITY: NEW YORK
STATE: NY
ZIP: 10023
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-01-14
0000907562
DYAX CORP
DYAX
0001261974
GRAY MARY ANN
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
1
0
0
0
Common Stock
2016-01-14
4
M
0
6000
2.97
A
16000
D
Common Stock
2016-01-14
4
M
0
75000
3.82
A
91000
D
Common Stock
2016-01-14
4
M
0
75000
2.09
A
166000
D
Common Stock
2016-01-14
4
M
0
8107
2.06
A
174107
D
Common Stock
2016-01-14
4
M
0
25000
6.17
A
199107
D
Common Stock
2016-01-14
4
M
0
33333
26.23
A
232440
D
Stock Option (right to buy)
2.97
2016-01-14
4
M
0
6000
0
D
2016-05-18
Common Stock
6000
0
D
Stock Option (right to buy)
3.82
2016-01-14
4
M
0
75000
0
D
2018-05-15
Common Stock
75000
0
D
Stock Option (right to buy)
2.09
2016-01-14
4
M
0
75000
0
D
2021-05-12
Common Stock
75000
0
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
8107
0
D
2017-06-20
Common Stock
8107
0
D
Stock Option (right to buy)
6.17
2016-01-14
4
M
0
25000
0
D
2024-05-08
Common Stock
25000
0
D
Stock Option (right to buy)
26.23
2016-01-14
4
M
0
33333
0
D
2025-05-12
Common Stock
33333
16667
D
The options became fully exercisable on May 15, 2008.
The options became fully exercisable on May 12, 2011.
The options became fully exercisable on May 8, 2014.
The options become exercisable in twelve (12) substantially equal installments on each monthly anniversary of the date of grant, May 12, 2015.
/s/ Stacie S. Aarestad, as attorney-in-fact
2016-01-19